Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice

Cell Death Differ. 2005 Jan;12(1):94-7. doi: 10.1038/sj.cdd.4401523.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenomatous Polyposis Coli / genetics
  • Adenomatous Polyposis Coli / pathology
  • Adenomatous Polyposis Coli / physiopathology
  • Adenomatous Polyposis Coli Protein / genetics*
  • Animals
  • Gene Expression / genetics
  • Heterozygote
  • Intestinal Neoplasms / genetics
  • Intestinal Neoplasms / pathology
  • Intestinal Neoplasms / physiopathology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mutation
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Receptors, Tumor Necrosis Factor / genetics
  • Receptors, Tumor Necrosis Factor / physiology*
  • Splenic Neoplasms / genetics
  • Splenic Neoplasms / pathology
  • Splenic Neoplasms / physiopathology
  • Thymus Neoplasms / genetics
  • Thymus Neoplasms / pathology
  • Thymus Neoplasms / physiopathology*
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • Adenomatous Polyposis Coli Protein
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Receptors, Tumor Necrosis Factor
  • Tnfrsf10b protein, mouse
  • Tumor Suppressor Protein p53